2Perlade DE Smulian AG Cushion MT.Molecular epidemiology and anti-biotic susceptible of Enterococci in Cincinnati, Ohio:a prospective cityside surgery[J].J Clin Microbiol,1997,35(9):2342-2342.
5Jone RN.Impact of changing pathogens and antimlcrobial susceptibility pat- terns in the treatment of serious infections in hospitalized patients[J]o Am J Med. 1996,100(6):3-12.
6Mandy LM,sahm DF,Gilmre M.Relationships between enterococcal viruleuce and antimicrobial resistanee[J].Clin Microbiol Rew,2000,13 (4):513-522.
7Galdbart J O,Morvon A,Solh N E,et al.Phenotypic and molecular typing of nosocomial methicillin-resistant Staphylococcus aureus strains susceptible to gentamicin isolated in France from 1995 to 1997[J].J Clin Microbiol,2000,38(1):185-190.
8Marcus V,Coimbra DS,Lenise A,et al.Spread of the Brazilian epidemic clone of a multiresistant MRSA in two cities in Argentina[J].J Med Microbiol,2000,49(1):187-192.
9Woodford N.Glycopeptide-resistant enterococci:a decade of experience[J].J Med Microbiol,1998,47(4):849-862.
10Alonso-Echanove J,Robles B,Jorvis W R,et al.Proficiency of clinical laboratories in Spain in detecting Vancomycin-resistant Enterococcus spp[J].J Clin Microbiol,1999,37(8):2148-2152.
